These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22065838)

  • 1. A NOD to zebrafish models of inflammatory bowel disease pathogenesis.
    Allen IC
    Dis Model Mech; 2011 Nov; 4(6):711-2. PubMed ID: 22065838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish.
    Oehlers SH; Flores MV; Hall CJ; Swift S; Crosier KE; Crosier PS
    Dis Model Mech; 2011 Nov; 4(6):832-41. PubMed ID: 21729873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology.
    Kutikhin AG
    Hum Immunol; 2011 Oct; 72(10):955-68. PubMed ID: 21745515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: Inflammatory bowel disease and genetics.
    Weersma RK; van Dullemen HM; van der Steege G; Nolte IM; Kleibeuker JH; Dijkstra G
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():57-65. PubMed ID: 18081650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.
    Ozbayer C; Kurt H; Kebapci MN; Gunes HV; Colak E; Degirmenci I
    J Clin Pharm Ther; 2017 Feb; 42(1):98-102. PubMed ID: 27885704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic disorders are complex in inflammatory bowel disease.
    Fukushima K
    J Gastroenterol; 2006 Apr; 41(4):393-4. PubMed ID: 16741623
    [No Abstract]   [Full Text] [Related]  

  • 7. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NOD1/CARD4 and NOD2/CARD15 genetic variations in lung cancer risk.
    Ozbayer C; Kurt H; Bayramoglu A; Gunes HV; Metintas M; Degirmenci İ; Oner KS
    Inflamm Res; 2015 Oct; 64(10):775-9. PubMed ID: 26238283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 in zebrafish functions in antibacterial and also antiviral responses via NF-κB, and also MDA5, RIG-I and MAVS.
    Zou PF; Chang MX; Li Y; Xue NN; Li JH; Chen SN; Nie P
    Fish Shellfish Immunol; 2016 Aug; 55():173-85. PubMed ID: 27235368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2.
    Maharana J; Dehury B; Sahoo JR; Jena I; Bej A; Panda D; Sahoo BR; Patra MC; Pradhan SK
    Mol Biosyst; 2015 Aug; 11(8):2324-36. PubMed ID: 26079944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
    Jakopin Ž
    J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
    Cantó E; Ricart E; Busquets D; Monfort D; García-Planella E; González D; Balanzó J; Rodriguez-Sanchez JL; Vidal S
    World J Gastroenterol; 2007 Nov; 13(41):5446-53. PubMed ID: 17907287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.
    Tattoli I; Travassos LH; Carneiro LA; Magalhaes JG; Girardin SE
    Semin Immunopathol; 2007 Sep; 29(3):289-301. PubMed ID: 17690884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
    Correa RG; Milutinovic S; Reed JC
    Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetics in inflammatory bowel disease.
    Henckaerts L; Figueroa C; Vermeire S; Sans M
    Curr Drug Targets; 2008 May; 9(5):361-8. PubMed ID: 18473763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD1 and NOD2 receptors: integral members of the innate and adaptive immunity system.
    Antosz H; Osiak M
    Acta Biochim Pol; 2013; 60(3):351-60. PubMed ID: 23901396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.